Zetia

ezetimibe · Merck & Co.

Drug timelines are a Plus or Pro feature.

55 regulatory and trial events tracked for Zetia, covering 2006-05-23 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn) [Phase 3]

See pricing